Results 141 to 150 of about 3,714 (189)

[Phenibut potentiation of the therapeutic action of antiparkinson agents].

Zhurnal nevropatologii i psikhiatrii imeni S.S. Korsakova (Moscow, Russia : 1952), 1986
It was observed in experiments on mice that the central action of phenibut (beta-phenyl-gamma-aminobutyric acid) diminished after destruction of brain dopaminergic neurons by 6-hydroxydopamine and after pretreatment with the dopamine receptor blocker haloperidol which suggests the dopaminergic component in the action of phenibut.
Iu V, Gol'dblat, I P, Lapin
openaire   +1 more source

Potential antiparkinsonism agents. Quinuclidinyl benzhydryl ethers

Journal of Medicinal Chemistry, 1969
J L, Nilsson, J, Wågermark, R, Dahlbom
openaire   +2 more sources

[Antiparkinson agents].

Nederlands tijdschrift voor geneeskunde, 1987
A L, Staal-Schreinemachers, J P, Lakke
openaire   +3 more sources

ANTIPARKINSON DRUGS AS CAUSAL AGENTS IN TARDIVE DYSKINESIA

Medical Journal of Australia, 1973
L G, Kiloh, J S, Smith, S E, Williams
openaire   +2 more sources

Antiparkinson Agents

2007
openaire   +1 more source

ANTIPARKINSON AGENTS

1965
openaire   +1 more source

Antiparkinson Agents

2018
openaire   +1 more source

[Antiparkinson agents. 50].

Pharmazeutische Praxis, 1971
F, Schmutzler, A, Eichhorn
openaire   +1 more source

[Antiparkinson agents].

Tijdschrift voor ziekenverpleging, 1977
A, van der Kuy, A A, van der Bemd, A J, Beysens   +2 more
openaire   +1 more source

L-Dopa codrugs containing antioxidant molecules as potential antiparkinson agents

2007
not ...
F. PINNEN, P. SOZIO, L. S. CERASA, A. IANNITELLI, I. CACCIATORE, A. COCCO, RICCIUTELLI, Massimo, GIORGIONI, Gianfabio, A. DI STEFANO   +8 more
openaire   +1 more source